我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

对比剂致急性肾损伤研究进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2015年第2期
页码:
241-245
栏目:
综述
出版日期:
2014-10-25

文章信息/Info

Title:
Research progress in contrast-induced acute kidney injury
作者:
李鸿杰1综述; 唐方明2审校
(1.广东医学院研究生院，广东 湛江 524000；
2.广东省农垦中心医院心血管内科，广东 湛江 524000)
Author(s):
LI Hong-jie1;  TANG Fang-ming2
(1.Graduate School, Guangdong Medical College, Zhanjiang 524000, Guangdong, China；
2.Department of Internal Medicine, Central Hospital, Guangdong Agriculture Reclamation, Zhanjiang 524000, Guangdong, China)
关键词:
对比剂; 急性肾损伤; 冠状动脉介入治疗;  水化
Keywords:
contrast media;  contrast-induced acute kidney injury;  prevention strategies;  coronary artery interventional therapy;  hydration
分类号:
R699.2
DOI:
-
文献标识码:
A
摘要:
随着冠状动脉介入治疗的快速发展，对比剂的使用越来越广泛，但随之出现的对比剂致急性肾损伤(CI-AKI)目前已成为医院内获得性急性肾衰竭的第3位原因，并且发病率和病死率逐年增加。虽然临床研究者对CI-AKI的发病机制及危险因素研究日趋加深，但由于目前仍缺乏切实有效的防治策略，CI-AKI仍然是重要的临床问题。本文将就CI-AKI的诊断标准、发病机制、危险因素、预防策略及近期研究进展做一综述。
Abstract:
With the rapid development of coronary artery interventional therapy, contrast media is used more and more widely, but contrast-induced acute kidney injury (CI-AKI) ranks as the third reason for hospital-acquired acute renal failure with a yearly increase in the incidence and mortality rate. Although more studies have been conducted on the pathogenesis and clinical risk of acute renal injury induced by the contrast factors, CI-AKI is still an important clinical problem due to lack of an effective strategy for the prevention of CI-AKI. This article will focus on the recent research progress in the diagnosis, pathogenesis, risk factors, and prevention strategies of CI-AKI.

参考文献/References

[1]Nikolsky E,Aymong ED,Dangas G,et al.Radiocontrast nephropathy;identifying the high-risk patient and the implications of exacerbating renal function[J].Rev Cardiovasc Med,2003,4(Suppl 1):S7-S14.
[2]Abizaid AS,Clark CE,Mintz GS,et al.Effects of dopamine andaminophyllinc on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency[J].Am J Cardiol,1999,83(2):260-263.
[3]Marenzi G,Assanelli E,Campodonico J,et al.Contrast volume during primary percutaneous coronary Intervention and subsequent contrast-induced nephropathy and mortality[J].Ann Intern Med,2009,150(3):170-177.
[4]Dong M,Jiao Z,Liu T,et al.Effect of administration route on the renal safety of contrast agents:a meta-analysis of randomized controlled trials[J].J Nephrol,2012,25(3):290-301.
[5]McCullough PA,Brown JR.Effects of infra-arterial and intravenousiso-osmolar contrast medium(Iodixanol)on the risk of contrast-induced acute kidney injury:a meta-analysis[J].Cardiorenal Med,2011,1(4):220-234.
[6]中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 含碘对比剂在心血管疾病中临床应用的专家共识(2012)[J].中华心血管病杂志,2013,41(2):94-98.
[7]Wright RS,Anderson JL,Adams CD,et al.2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction(updating the 2007 guideline):a report of he American College of Cardiology Foundation/American Heart Association task force on practice guidelines[J].Circulation,2011,123(18):2022-2060.
[8]Klein LW,Sheldon MW,Brinker J,et al.The use of radiographic contrast media during PCI:a focused review:a position statement of the Society of Cardiovascular Angiography and Interventions[J].Catheter Cardiovasc Interv,2009,74(5):728-746.
[9]Weisbord SD,Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion[J].Clin J Am Soc Nephrol,2008,3(1):273-280.
[10]Jang JS,Jin HY,Seo JS,et al.Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury- a systematic review and meta-analysis -[J].Circulation,2012,76(9):2255-2265.
[11]Kunadian V,Zaman A,Spyridopoulos I,et al.Sodium bicarbonate for the prevention of contrast induced nephropathy:a meta-analysis of published clinical trials[J].Eur J Radiol,2011,79(1):48-55.
[12]Adolph E,Holdt-Lehmann B,Chatterjee T,et al.Renal insufficiency following radiocontrast exposure trial(REINFORCE):a randomized comparison of Sodium bicarbonate versus Sodium chloride hydration for the prevention of contrast-induced nephropathy[J].Coron Artery Dis,2008,19(6):413-419.
[13]Kanbay M,Covic A,Coca SG,et al.Sodium bicarbonate for the prevention of contrast-induced nephropathy:a meta-analysis of 17 randomized trials[J].Int Urol Nephrol,2009,41(3):617-627.
[14]Han Y,Zhu G,Han L,et al.Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease［J］. J Am Coll Cardiol, 2014, 63(1):62-70.
[15]Jo SH, Koo BK, Park JS, et al. Prevention of radio-contrast medium-induced nephropathy using short-term high dose simvastatin in patients with renal insufficiency undergoing coronary angiography(PROMISS)trial-a randomized controlled study[J].The American Heart,2008,155(3):499.
[16]Toso A,Maioli M,Leoncini M,et al.Usefulness of atorvastatin(80 mg)in prevention of contrast-induced nephropathy in patients with chronic renal disease[J].Am J Cardiol,2010,105(3):288-292.
[17]Kwok CS,Pang CL,Yeong JK,et al.Measures used to treat contrast-induced nephropathy:overview of reviews[J].Br J Radiol,2013,86(1021):20120272.
[18]Wilson DK,Van Horn ML,Kitzman-Ulrich H,et al.The results of the“Active by Choice Today”(ACT)trial for increasing moderate-to-vigorous physical activity(MVPA) in low-income and minority adolescents[J].Health Psychol,2011,30(4):463-471.
[19]Matejka J,Varvarovsky I,Vojtisek P,et al.Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease[J].Heart Vessels,2010,25(6):536-542.
[20]Dai B,Liu Y,Fu L,et al.Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials[J].Am J Kidney Dis,2012,60(3):360-370.
[21]Gurkowski L,MacDougall M,Wiegmann T.Effects of misoprostol on contrast-induced renal dysfunction[J].Am J Ther,1995,2(11),837-842.
[22]Spargias K,Adreanides E,Demerouti E,et al.Lloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention[J].Circulation,2009,120(18):1793-1799.
[23]Brewster UC,Perazella MA.The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease[J].Am J Med,2004,116(4):263-272.
[24]Saudan P,Muller H,Feraille E,et al.Renin-angiotensin system blockade and contrast-induced renal toxicity[J].J Nephrol,2008,21(5):681-685.
[25]钱越洲,朱利民,刘 宇,等.黄芪注射液预防冠状动脉介入后造影剂肾病的研究[J].中国现代医生,2008,46(13):33-34.
[26]龚学忠,王 骞,符 丹,等.制大黄-川芎“药对”抑制造影剂肾病大鼠肾小管上皮细胞凋亡信号通路的机制研究[J].上海中医药杂志,2013(3):69-71.
[27]Cruz DN,Goh CY,Marenzi G,et al.Renal replacement therapies for prevention of Radio contrast-induced nephropathy:a systematic review[J].Am J Med,2012,125(1):66-78.
[28]Er F,Nia AM,Dopp H,et al.Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial(Renal Protection Trial)[J].Circulation,2012,126(3):296-303.
[29]Michishita I,Fujii Z.A novel contrast removal system from the coronary sinus using an adsorbing column during coronary angiography in a porcine model[J].J Am Coll Cardiol,2006,47(9):1866-1870.
[30]Moore EM,Nichol AD,Bernard SA,et al.Therapeutic hypothermia:Benefits, mechanisms and potential clinical applications in neurological, cardiac and kidney injury[J].Injury,2011,42(9):843-854.

备注/Memo

备注/Memo:
收稿日期：2014-05-08.
通讯作者：唐方明，主任医师，主要从事介入心脏病学研究 Email：13828236679@139.com
作者简介：李鸿杰，硕士 Email：pulushilan@126.com
更新日期/Last Update: 2014-11-18